At the ESMO Congress 2024, Syed Hussain, MBBS, MSc, MD, FRCP, of the University of Sheffield Medical School, provides his thoughts on how and why to increase worldwide attention on rare forms of bladder cancer, including areas of unmet need in clinical trials and novel treatments.
Having a session at the ESMO Congress dedicated to rare and variant bladder cancers is great, he notes, but only the first step in moving initiatives forward.
View his previous comments on Rare and Variant Histologies in Bladder Cancer.